-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on WAVE Life Sciences, Raises Price Target to $14

Benzinga·05/20/2026 13:30:30
Listen to the news
Wells Fargo analyst Benjamin Burnett maintains WAVE Life Sciences (NASDAQ:WVE) with a Overweight and raises the price target from $13 to $14.